INR 51.0
(-0.6%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 163.96 Million INR | 1.94% |
2022 | 160.84 Million INR | 1.78% |
2021 | 158.02 Million INR | 2.0% |
2020 | 154.92 Million INR | 2.33% |
2019 | 151.39 Million INR | -0.41% |
2018 | 152.01 Million INR | -7.71% |
2017 | 164.71 Million INR | -0.09% |
2016 | 164.86 Million INR | 36.37% |
2015 | 120.89 Million INR | 31.29% |
2014 | 92.08 Million INR | -4.22% |
2013 | 96.14 Million INR | -70.88% |
2012 | 330.16 Million INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 162.95 Million INR | -0.62% |
2023 Q1 | 161.86 Million INR | 0.63% |
2023 Q2 | 162.5 Million INR | 0.4% |
2023 FY | 163.96 Million INR | 1.94% |
2023 Q3 | 163.2 Million INR | 0.43% |
2023 Q4 | 163.96 Million INR | 0.47% |
2022 FY | 160.84 Million INR | 1.78% |
2022 Q4 | 160.84 Million INR | 0.39% |
2022 Q1 | 159.01 Million INR | 0.63% |
2022 Q3 | 160.22 Million INR | 0.39% |
2022 Q2 | 159.59 Million INR | 0.36% |
2021 Q4 | 158.02 Million INR | 0.43% |
2021 Q2 | 156.9 Million INR | 0.58% |
2021 Q1 | 155.99 Million INR | 0.69% |
2021 FY | 158.02 Million INR | 2.0% |
2021 Q3 | 157.34 Million INR | 0.28% |
2020 Q1 | - INR | -100.0% |
2020 FY | 154.92 Million INR | 2.33% |
2020 Q4 | 154.92 Million INR | 0.0% |
2019 Q4 | 151.39 Million INR | 0.0% |
2019 FY | 151.39 Million INR | -0.41% |
2019 Q1 | - INR | -100.0% |
2018 FY | 152.01 Million INR | -7.71% |
2018 Q4 | 152.01 Million INR | 0.0% |
2018 Q3 | - INR | -100.0% |
2018 Q2 | 166.47 Million INR | 0.0% |
2018 Q1 | - INR | -100.0% |
2017 Q4 | 164.71 Million INR | 0.0% |
2017 FY | 164.71 Million INR | -0.09% |
2017 Q1 | - INR | -100.0% |
2016 Q2 | 121.42 Million INR | 0.0% |
2016 FY | 164.86 Million INR | 36.37% |
2016 Q4 | 164.86 Million INR | 0.0% |
2016 Q3 | - INR | -100.0% |
2015 Q4 | 120.89 Million INR | 0.0% |
2015 Q3 | - INR | -100.0% |
2015 Q2 | 91.66 Million INR | 0.0% |
2015 Q1 | - INR | -100.0% |
2015 FY | 120.89 Million INR | 31.29% |
2014 Q3 | - INR | -100.0% |
2014 Q1 | - INR | -100.0% |
2014 Q4 | 92.08 Million INR | 0.0% |
2014 FY | 92.08 Million INR | -4.22% |
2014 Q2 | 92.26 Million INR | 0.0% |
2013 Q1 | - INR | -100.0% |
2013 FY | 96.14 Million INR | -70.88% |
2013 Q4 | 96.14 Million INR | 0.0% |
2012 FY | 330.16 Million INR | 0.0% |
2012 Q4 | 330.16 Million INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Ador Multiproducts Limited | 28.52 Million INR | -474.765% |
Ambica Agarbathies Aroma & Industries Limited | 1.09 Billion INR | 85.091% |
Bajaj Consumer Care Limited | 1.53 Billion INR | 89.283% |
Colgate-Palmolive (India) Limited | 13.22 Billion INR | 98.76% |
Cupid Limited | 186.52 Million INR | 12.093% |
Dabur India Limited | 48.19 Billion INR | 99.66% |
Emami Limited | 8.21 Billion INR | 98.005% |
Gillette India Limited | 8.59 Billion INR | 98.092% |
Godrej Consumer Products Limited | 58.97 Billion INR | 99.722% |
Hindustan Unilever Limited | 270.76 Billion INR | 99.939% |
Hipolin Limited | 48.57 Million INR | -237.572% |
Honasa Consumer Limited | 5.36 Billion INR | 96.945% |
JHS Svendgaard Laboratories Limited | 271.7 Million INR | 39.652% |
Jyothy Labs Limited | 5.9 Billion INR | 97.224% |
Kaya Limited | 5.22 Billion INR | 96.86% |
Marico Limited | 32.52 Billion INR | 99.496% |
N.K Industries Limited | 22.4 Billion INR | 99.268% |
Paramount Cosmetics (India) Limited | 205.72 Million INR | 20.297% |
Pee Cee Cosma Sope Limited | 80.17 Million INR | -104.504% |
Procter & Gamble Hygiene and Health Care Limited | 10.83 Billion INR | 98.487% |